Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Mar 2023 for Abbott Laboratories, €526k. Read the official filing
Filing timeline
BuySaleJared Watkin
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jared Watkin: trading record in brief
All filings by Jared Watkin on record concern Abbott Laboratories, in the capacity of chief executive. In total, 5 filings cover trades dated from 30 April 2021 to 28 February 2023.
On the market, this insider has only sold: 1 sale, €943k in total. Besides market trades, the filings include 4 share grants.
The latest filing, published on 2 March 2023, reports a share grant of €526k in Abbott Laboratories. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jared Watkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
5,598 shares@ US$99.7716.7% of flowCommon shares without par valueSEC:0001415889-23-003922:0
11,617 shares0Common shares without par valueSEC:0001415889-23-003072:0
6,759 shares@ US$122.410.0003% mcap28.2% of flowCommon shares without par valueSEC:0001415889-22-002203:0
14,559 shares0Common shares without par valueSEC:0001415889-22-001748:0
9,533 shares@ US$120.01642.7% of flowCommon shares without par valueSEC:0001415889-21-002268:0
5 of 5 declarations
